FDA Inspection 1280399 — CorePharma, LLC
The FDA completed an inspection of CorePharma, LLC on Aug 28, 2025 in Middlesex, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 28, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Middlesex, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)